77 related articles for article (PubMed ID: 30603996)
1. Association between breast cancer risk factors and molecular type in postmenopausal patients with hormone receptor-positive early breast cancer.
Wunderle M; Pretscher J; Brucker SY; Volz B; Hartmann A; Fiessler C; Hein A; Häberle L; Jud SM; Lux MP; Janni W; Loehberg CR; Hartkopf AD; Walter CB; Baake G; Fridman A; Malter W; Wuerstlein R; Harbeck N; Hoffmann O; Kümmel S; Martin B; Thomssen C; Graf H; Wolf C; Bayer CM; Hack CC; Almstedt K; Gass P; Heindl F; Brodkorb TF; Nabieva N; Lindner C; Kolberg HC; Krabisch P; Weigel M; Steinfeld-Birg D; Kohls A; Brucker C; Schulz V; Fischer G; Pelzer V; Wallwiener D; Rack B; Fehm T; Rody A; Maass N; Beckmann MW; Fasching PA; Rauh C
Breast Cancer Res Treat; 2019 Apr; 174(2):453-461. PubMed ID: 30603996
[TBL] [Abstract][Full Text] [Related]
2. Reproductive and hormonal risk factors for luminal, HER2-overexpressing, and triple-negative breast cancer in Japanese women.
Islam T; Matsuo K; Ito H; Hosono S; Watanabe M; Iwata H; Tajima K; Tanaka H
Ann Oncol; 2012 Sep; 23(9):2435-2441. PubMed ID: 22328736
[TBL] [Abstract][Full Text] [Related]
3. Body size and weight change over adulthood and risk of breast cancer by menopausal and hormone receptor status: a pooled analysis of 20 prospective cohort studies.
van den Brandt PA; Ziegler RG; Wang M; Hou T; Li R; Adami HO; Agnoli C; Bernstein L; Buring JE; Chen Y; Connor AE; Eliassen AH; Genkinger JM; Gierach G; Giles GG; Goodman GG; Håkansson N; Krogh V; Le Marchand L; Lee IM; Liao LM; Martinez ME; Miller AB; Milne RL; Neuhouser ML; Patel AV; Prizment A; Robien K; Rohan TE; Sawada N; Schouten LJ; Sinha R; Stolzenberg-Solomon RZ; Teras LR; Tsugane S; Visvanathan K; Weiderpass E; White KK; Willett WC; Wolk A; Zeleniuch-Jacquotte A; Smith-Warner SA
Eur J Epidemiol; 2021 Jan; 36(1):37-55. PubMed ID: 33128203
[TBL] [Abstract][Full Text] [Related]
4. Association between menopausal hormone therapy, mammographic density and breast cancer risk: results from the E3N cohort study.
Fornili M; Perduca V; Fournier A; Jérolon A; Boutron-Ruault MC; Maskarinec G; Severi G; Baglietto L
Breast Cancer Res; 2021 Apr; 23(1):47. PubMed ID: 33865453
[TBL] [Abstract][Full Text] [Related]
5. Body size and risk of luminal, HER2-overexpressing, and triple-negative breast cancer in postmenopausal women.
Phipps AI; Malone KE; Porter PL; Daling JR; Li CI
Cancer Epidemiol Biomarkers Prev; 2008 Aug; 17(8):2078-86. PubMed ID: 18664548
[TBL] [Abstract][Full Text] [Related]
6. Association between lifetime exposure to passive smoking and risk of breast cancer subtypes defined by hormone receptor status among non-smoking Caucasian women.
Strumylaite L; Kregzdyte R; Poskiene L; Bogusevicius A; Pranys D; Norkute R
PLoS One; 2017; 12(2):e0171198. PubMed ID: 28151962
[TBL] [Abstract][Full Text] [Related]
7. Racial/ethnic differences in postmenopausal breast cancer risk by hormone receptor status: The multiethnic cohort study.
Sarink D; White KK; Loo LWM; Wu AH; Wilkens LR; Le Marchand L; Park SY; Setiawan VW; Merritt MA
Int J Cancer; 2022 Jan; 150(2):221-231. PubMed ID: 34486728
[TBL] [Abstract][Full Text] [Related]
8. Association of the joint effect of menopause and hormone replacement therapy and cancer in African American women: the Jackson Heart Study.
Campbell Jenkins BW; Addison C; Wilson G; Liu J; Fortune M; Robinson K; White M; Sarpong D
Int J Environ Res Public Health; 2011 Jun; 8(6):2491-504. PubMed ID: 21776241
[TBL] [Abstract][Full Text] [Related]
9. Reproductive risk factors associated with breast cancer in young women by molecular subtype.
Ruddy KJ; Vierkant RA; Jahan N; Higgins A; Partridge A; Larson N; Radisky DC; Couch F; Olson J; Sherman ME
Breast; 2022 Dec; 66():272-277. PubMed ID: 36375388
[TBL] [Abstract][Full Text] [Related]
10. Hormone replacement therapy use dramatically increases breast oestrogen receptor expression in obese postmenopausal women.
Lawson JS; Field AS; Tran DD; Houssami N
Breast Cancer Res; 2001; 3(5):342-5. PubMed ID: 11597325
[TBL] [Abstract][Full Text] [Related]
11. Breast Cancer in Patients with Previous Endometriosis Showed Low Aggressive Subtype.
Vanni G; Selntigia A; Marsella VE; Russo C; Pellicciaro M; Materazzo M; Rizzo G; Buonomo OC; Exacoustos C
Medicina (Kaunas); 2024 Apr; 60(4):. PubMed ID: 38674271
[No Abstract] [Full Text] [Related]
12. Hormone-replacement therapy influences gene expression profiles and is associated with breast-cancer prognosis: a cohort study.
Hall P; Ploner A; Bjöhle J; Huang F; Lin CY; Liu ET; Miller LD; Nordgren H; Pawitan Y; Shaw P; Skoog L; Smeds J; Wedrén S; Ohd J; Bergh J
BMC Med; 2006 Jun; 4():16. PubMed ID: 16813654
[TBL] [Abstract][Full Text] [Related]
13. Risk prediction for estrogen receptor-specific breast cancers in two large prospective cohorts.
Li K; Anderson G; Viallon V; Arveux P; Kvaskoff M; Fournier A; Krogh V; Tumino R; Sánchez MJ; Ardanaz E; Chirlaque MD; Agudo A; Muller DC; Smith T; Tzoulaki I; Key TJ; Bueno-de-Mesquita B; Trichopoulou A; Bamia C; Orfanos P; Kaaks R; Hüsing A; Fortner RT; Zeleniuch-Jacquotte A; Sund M; Dahm CC; Overvad K; Aune D; Weiderpass E; Romieu I; Riboli E; Gunter MJ; Dossus L; Prentice R; Ferrari P
Breast Cancer Res; 2018 Dec; 20(1):147. PubMed ID: 30509329
[TBL] [Abstract][Full Text] [Related]
14. Excess body weight and postmenopausal breast cancer: Emerging molecular mechanisms and perspectives.
Nahmias-Blank D; Maimon O; Meirovitz A; Sheva K; Peretz-Yablonski T; Elkin M
Semin Cancer Biol; 2023 Nov; 96():26-35. PubMed ID: 37739109
[TBL] [Abstract][Full Text] [Related]
15. Prognostic correlations with the microbiome of breast cancer subtypes.
Banerjee S; Wei Z; Tian T; Bose D; Shih NNC; Feldman MD; Khoury T; De Michele A; Robertson ES
Cell Death Dis; 2021 Sep; 12(9):831. PubMed ID: 34482363
[TBL] [Abstract][Full Text] [Related]
16. Patterns of Chromosomal Instability and Clonal Heterogeneity in Luminal B Breast Cancer: A Pilot Study.
Camargo-Herrera V; Castellanos G; Rangel N; Jiménez-Tobón GA; Martínez-Agüero M; Rondón-Lagos M
Int J Mol Sci; 2024 Apr; 25(8):. PubMed ID: 38674062
[TBL] [Abstract][Full Text] [Related]
17. Interaction of sedentary behaviour and educational level in breast cancer risk.
Pinto-Carbó M; Vanaclocha-Espí M; Ibañez J; Martín-Pozuelo J; Romeo-Cervera P; Nolasco A; Besó-Delgado M; Castán-Cameo S; Salas D; Molina-Barceló A
PLoS One; 2024; 19(5):e0300349. PubMed ID: 38753623
[TBL] [Abstract][Full Text] [Related]
18. Lipid profile in breast cancer: From signaling pathways to treatment strategies.
Taborda Ribas H; Sogayar MC; Dolga AM; Winnischofer SMB; Trombetta-Lima M
Biochimie; 2024 Apr; 219():118-129. PubMed ID: 37993054
[TBL] [Abstract][Full Text] [Related]
19. The Breast Cancer Single-Cell Atlas: Defining cellular heterogeneity within model cell lines and primary tumors to inform disease subtype, stemness, and treatment options.
Dave A; Charytonowicz D; Francoeur NJ; Beaumont M; Beaumont K; Schmidt H; Zeleke T; Silva J; Sebra R
Cell Oncol (Dordr); 2023 Jun; 46(3):603-628. PubMed ID: 36598637
[TBL] [Abstract][Full Text] [Related]
20. Estrogen-Receptor-Positive Breast Cancer in Postmenopausal Women: The Role of Body Composition and Physical Exercise.
Dimauro I; Grazioli E; Antinozzi C; Duranti G; Arminio A; Mancini A; Greco EA; Caporossi D; Parisi A; Di Luigi L
Int J Environ Res Public Health; 2021 Sep; 18(18):. PubMed ID: 34574758
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
